Variation in how side effects are reported leaves first impressions of new anti-cancer drugs open to manipulation
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant ...
Apr 28, 2020
0
2